{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:31:05Z","timestamp":1787927465423,"version":"build-2784847793"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","primary-care-diabetes.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Primary Care Diabetes"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pcd.2026.01.005","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:28:01Z","timestamp":1768566481000},"page":"211-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany"],"prefix":"10.1016","volume":"20","author":[{"given":"L.","family":"Hilgefort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Potthoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nambiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Schlottmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Kaup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ebigbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.E.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Nonseid-Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.A.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Skaletz-Rorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.R.","family":"Quast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.pcd.2026.01.005_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7954","article-title":"Comparison of overall and comorbidity-free life expectancy between insured adults with and without HIV infection, 2000-2016","volume":"3","author":"Marcus","year":"2020","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.pcd.2026.01.005_bib2","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2991\/jegh.k.210621.001","article-title":"Global epidemiology of HIV\/AIDS: a resurgence in North America and Europe","volume":"11","author":"Govender","year":"2021","journal-title":"J. Epidemiol. Glob. Health"},{"issue":"4","key":"10.1016\/j.pcd.2026.01.005_bib3","doi-asserted-by":"crossref","first-page":"e279","DOI":"10.1016\/S2352-3018(20)30036-9","article-title":"HIV and cardiovascular disease","volume":"7","author":"So-Armah","year":"2020","journal-title":"Lancet HIV"},{"key":"10.1016\/j.pcd.2026.01.005_bib4","doi-asserted-by":"crossref","DOI":"10.1097\/CM9.0000000000003560","article-title":"Increasing trends of hyperglycemia and diabetes in treatment-naive people living with HIV in Shenzhen from 2013 to 2019: An emerging health concern","author":"Sun","year":"2025","journal-title":"Chin. Med J. (Engl. )"},{"issue":"11","key":"10.1016\/j.pcd.2026.01.005_bib5","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with HIV: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pcd.2026.01.005_bib6","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/QAI.0000000000002798","article-title":"HIV Infection Is associated With type 2 diabetes mellitus","volume":"88","author":"Hogh","year":"2021","journal-title":"J. Acquir Immune Defic. Syndr."},{"key":"10.1016\/j.pcd.2026.01.005_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol. Metab."},{"issue":"5","key":"10.1016\/j.pcd.2026.01.005_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S2213-8587(16)00052-8","article-title":"Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular events, death, and major safety outcomes in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"4","author":"Wu","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"3","key":"10.1016\/j.pcd.2026.01.005_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00392-012-0519-0","article-title":"Prevalence of cardiovascular diseases in HIV-infected outpatients: results from a prospective, multicenter cohort study","volume":"102","author":"Esser","year":"2013","journal-title":"Clin. Res Cardiol."},{"issue":"2","key":"10.1016\/j.pcd.2026.01.005_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1741826711398431","article-title":"Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study","volume":"19","author":"Reinsch","year":"2012","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.pcd.2026.01.005_bib11","unstructured":"American Diabetes Association Professional Practice Committee. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2025 ement_1 48 Diabetes Care2025."},{"key":"10.1016\/j.pcd.2026.01.005_bib12","series-title":"Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF)","author":"Bundes\u00e4rztekammer","year":"2023"},{"issue":"ement_1","key":"10.1016\/j.pcd.2026.01.005_bib13","doi-asserted-by":"crossref","first-page":"S207","DOI":"10.2337\/dc25-S010","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2025","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.pcd.2026.01.005_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/hiv.70120","article-title":"Major revision version 13.0 of the European AIDS Clinical Society guidelines 2025","volume":"27","author":"Ambrosioni","year":"2026","journal-title":"HIV Med"},{"key":"10.1016\/j.pcd.2026.01.005_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.mehy.2016.07.016","article-title":"Glucagon like peptide-1 receptor agonists may ameliorate the metabolic adverse effect associated with antiretroviral therapy","volume":"94","author":"Culha","year":"2016","journal-title":"Med Hypotheses"},{"issue":"11","key":"10.1016\/j.pcd.2026.01.005_bib16","first-page":"e45","article-title":"HIV first diagnoses in Germany in 2014 - a regional analysis","volume":"84","author":"Thomas Schleenvoigt","year":"2022","journal-title":"Gesundheitswesen"},{"issue":"1","key":"10.1016\/j.pcd.2026.01.005_bib17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/QAI.0000000000003227","article-title":"Brief report: use and side effects of sodium-glucose transporter 2 inhibitors among US people with HIV with clinical indications","volume":"94","author":"Sise","year":"2023","journal-title":"J. Acquir Immune Defic. Syndr."},{"issue":"6","key":"10.1016\/j.pcd.2026.01.005_bib18","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1071\/SH22070","article-title":"Under-utilisation of cardioprotective glucose-lowering medication in diabetics living with HIV","volume":"19","author":"Butale","year":"2022","journal-title":"Sex. Health"},{"issue":"47","key":"10.1016\/j.pcd.2026.01.005_bib19","first-page":"804","article-title":"Clinical practice guideline: shared decision making, diagnostic evaluation, and pharmacotherapy in type 2 diabetes","volume":"120","author":"Brockamp","year":"2023","journal-title":"Dtsch Arztebl Int"},{"issue":"3","key":"10.1016\/j.pcd.2026.01.005_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/17571472.2017.1302872","article-title":"Human immunodeficiency virus and type 2 diabetes","volume":"9","author":"Avari","year":"2017","journal-title":"Lond. J. Prim. Care (Abingdon)"},{"issue":"1","key":"10.1016\/j.pcd.2026.01.005_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1758-5996-3-2","article-title":"Understanding diabetes in patients with HIV\/AIDS","volume":"3","author":"Kalra","year":"2011","journal-title":"Diabetol. Metab. Syndr."},{"issue":"9","key":"10.1016\/j.pcd.2026.01.005_bib22","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1111\/dom.13367","article-title":"Insulin therapy, weight gain and prognosis","volume":"20","author":"Hodish","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.pcd.2026.01.005_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.24875\/AIDSRev.22000026","article-title":"Antiretroviral therapy and weight gain in antiretroviral treatment-experienced HIV patients: A review","volume":"25","author":"Dupont","year":"2023","journal-title":"AIDS Rev."},{"issue":"6","key":"10.1016\/j.pcd.2026.01.005_bib24","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/cid\/ciz999","article-title":"Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials","volume":"71","author":"Sax","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"5","key":"10.1016\/j.pcd.2026.01.005_bib25","first-page":"579","article-title":"Weighing In: Glucagon-Like Peptide-1 Receptor Agonism for Persons With HIV","volume":"32","author":"Thomas","year":"2024","journal-title":"Top. Antivir. Med"},{"key":"10.1016\/j.pcd.2026.01.005_bib26","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.3389\/fpubh.2022.1031306","article-title":"The prescribing pattern of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists in patient with type two diabetes mellitus: A two-center retrospective cross-sectional study","volume":"10","author":"Korayem","year":"2022","journal-title":"Front. Public Health"},{"issue":"1","key":"10.1016\/j.pcd.2026.01.005_bib27","article-title":"Knowledge gap and prescribing patterns of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors among Chinese doctors","volume":"14","author":"Liu","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pcd.2026.01.005_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.healthpol.2025.105426","article-title":"Can de-budgeting save primary care in Germany? A turning point for general practice","volume":"161","author":"Mohebbi","year":"2025","journal-title":"Health Policy"},{"issue":"4","key":"10.1016\/j.pcd.2026.01.005_bib29","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/cd22-0100","article-title":"Health Care Provider Prescribing Habits and Barriers to Use of New Type 2 Diabetes Medications: A Single-System Survey Study","volume":"41","author":"Yaseen","year":"2023","journal-title":"Clin. Diabetes"},{"issue":"5","key":"10.1016\/j.pcd.2026.01.005_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2013.20","article-title":"A Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3-O-glucuronide in Renal or Hepatic Impairment","volume":"2","author":"van der Walt","year":"2013","journal-title":"CPT Pharmacomet. Syst. Pharm."},{"issue":"10","key":"10.1016\/j.pcd.2026.01.005_bib31","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/hiv.13521","article-title":"GLP-1 agonists for people living with HIV and obesity, is there a potential?","volume":"24","author":"Zino","year":"2023","journal-title":"HIV Med"},{"key":"10.1016\/j.pcd.2026.01.005_bib32","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: a systematic review","volume":"142","author":"Roy","year":"2012","journal-title":"J. Affect Disord."},{"issue":"4","key":"10.1016\/j.pcd.2026.01.005_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1136\/bmjspcare-2019-001952","article-title":"Global prevalence of depression in HIV\/AIDS: a systematic review and meta-analysis","volume":"9","author":"Rezaei","year":"2019","journal-title":"BMJ Support Palliat. Care"},{"key":"10.1016\/j.pcd.2026.01.005_bib34","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpsychires.2023.05.041","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists as a protective factor for incident depression in patients with diabetes mellitus: A systematic review","volume":"164","author":"Cooper","year":"2023","journal-title":"J. Psychiatr. Res"},{"issue":"5","key":"10.1016\/j.pcd.2026.01.005_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020688","article-title":"Physical activity among HIV-positive patients receiving antiretroviral therapy in Hanoi and Nam Dinh, Vietnam: a cross-sectional study","volume":"8","author":"Dang","year":"2018","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.pcd.2026.01.005_bib36","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jdiacomp.2018.01.005","article-title":"Measurement of psychological adjustment to diabetes with the diabetes acceptance scale","volume":"32","author":"Schmitt","year":"2018","journal-title":"J. Diabetes Complicat."}],"container-title":["Primary Care Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000057?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1751991826000057?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:05:25Z","timestamp":1787925925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1751991826000057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S1751991826000057"],"URL":"https:\/\/doi.org\/10.1016\/j.pcd.2026.01.005","relation":{},"ISSN":["1751-9918"],"issn-type":[{"value":"1751-9918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT-2 inhibitors and GLP-1 receptor agonists in primary care pharmacotherapy of type 2 diabetes in people living with HIV versus HIV-negative controls: Findings from a multicenter study in Germany","name":"articletitle","label":"Article Title"},{"value":"Primary Care Diabetes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcd.2026.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.","name":"copyright","label":"Copyright"}]}}